Efficacy of dapsone in two cases of amyopathic dermatomyositis

Anais Brasileiros de Dermatologia

Volumn 81, Issue 2, 2006, Pages 181-182

  Galrão, Liliana D'Almeida ^a   Reale, Jean ^b   Lima, Isabella ^a   Santiago, Mittermayer ^a,c  

^a HOSPITAL SANTA IZABEL   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

Author keywords

Autoimmune diseases; Dapsone; Dermatomyositis

Indexed keywords

CHLOROQUINE; DAPSONE; HYDROXYCHLOROQUINE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; PHYSICAL EXAMINATION;

EID: 34248675788     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/s0365-05962006000200011     Document Type: Article

References (6)

1. Callen JP. Treatment of cutaneous lesions in patients with lupus erythematosus. Dermatol Clin. 1994;12:201-6.
2. Cohen JB. Cutaneous involvement of dermatomyositis can respond to dapsone therapy. Int J Dermatol. 2002;41:182-4.
3. Sontheimer R. Cutaneous features of classic dermato myositis and amyopathic dermatomyositis. Curr Opin Rheumatol. 1999;11:475-82.
4. Coleman MD. Dapsone: models of action, toxicity, and possible strategies for increasing patient tolerance. Br J Dermatol. 1993;129:507-13.
5. Tsutsui K, Imai T, Hatta N, Sakai H, Takata M, Takehara K. Widespread pruritic plaques in a patient with subacute lupus erythematosus and hypocomple mentemia: response to dapsone therapy. J Am Acad Dermatol. 1996;35:133-5.
6. Konohana A, Kawashima J. Successful treatment of dermatomyositis with dapsone. Clin Exp Dermatol. 1994;69:367.